Mark Christianson - 21 Mar 2023 Form 4 Insider Report for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)

Role
Business Development Director
Signature
/s/ Stephanie Swan, by Power of Attorney
Issuer symbol
NMTC
Transactions as of
21 Mar 2023
Net transactions value
-$40,097
Form type
4
Filing time
24 Mar 2023, 15:48:10 UTC
Previous filing
07 Feb 2023
Next filing
04 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NMTC Common Stock Sale $3,405 -2,122 -0.58% $1.60 361,872 21 Mar 2023 Direct F1
transaction NMTC Common Stock Sale $17,600 -11,667 -3.2% $1.51 350,205 22 Mar 2023 Direct F2
transaction NMTC Common Stock Sale $19,092 -12,711 -3.6% $1.50 337,494 23 Mar 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $1.60 to $1.61 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
F2 The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $1.50 to $1.515 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
F3 The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $1.50 to $1.52 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.